Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment
ACS Nano · 28.01.2025 · 19 (3) · 3455-3469
DOI: 10.1021/acsnano.4c12917 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 16.01.2025. Verfasst von Mi Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of S…. Hauptthemen laut MEDLINE: Neutrophils, Nucleic Acids, Flavonoids, Drug Delivery Systems. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: West China School of Stomatology, Sichuan University, China Postdoctoral Science Foundation, Sichuan Province Youth Science and Technology Innovation Team.
Abstract (Originalsprache)
Targeted drug delivery is a promising strategy for treating inflammatory diseases, with recent research focusing on the combination of neutrophils and nanomaterials. In this study, a targeted nanodrug delivery platform (Ac-PGP-tFNA, APT) was developed using tetrahedral framework nucleic acid (tFNA) along with a neutrophil hitchhiking mechanism to achieve precise delivery and anti-inflammatory effects. The tFNA structure, known for its excellent drug-loading capacity and cellular uptake efficiency, was used to carry a therapeutic agent─baicalin. The results demonstrate that the development of this drug delivery platform not only considerably enhances the bioavailability and effective concentration of the drug (baicalin) but also promotes the polarization of pro-inflammatory M1 macrophages to anti-inflammatory M2 macrophages by modulating the interactions between the neutrophils and macrophages. This targeted therapeutic method effectively treats inflammatory conditions such as sepsis and introduces a strategy for managing inflammatory diseases characterized by neutrophil infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China.
- Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu, Sichuan 610041, China.
- National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Xiaoxiao Cai, Yunfeng Lin
Förderung
- West China School of Stomatology, Sichuan University
- China Postdoctoral Science Foundation
- Sichuan Province Youth Science and Technology Innovation Team
- Science and Technology Department of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Zhou, M., Tang, Y., Lu, Y., Zhang, T., Zhang, S., Cai, X., & Lin, Y. (2025). Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment. ACS Nano, 19(3), 3455-3469. https://doi.org/10.1021/acsnano.4c12917
Vancouver
Zhou M, Tang Y, Lu Y, Zhang T, Zhang S, Cai X, et al. Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment. ACS Nano. 2025;19(3):3455-3469. doi:10.1021/acsnano.4c12917
BibTeX
@article{Zhou2025,
author = {Zhou, Mi and Tang, Yuanlin and Lu, Yifei and Zhang, Tianxu and Zhang, Shunhao and Cai, Xiaoxiao and Lin, Yunfeng},
title = {Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {3},
pages = {3455--3469},
doi = {10.1021/acsnano.4c12917}
}
EUVIMED